Purpose/ Objective

Cardiac magnetic resonance (CMR) imaging is a well-established noninvasive imaging modality in clinical cardiology. Its unsurpassed accuracy in defining cardiac morphology and function and its ability to provide tissue characterization make it well suited for the study of patients with cardiac diseases. Late gadolinium enhancement was a major advancement in the development of tissue characterization techniques, allowing the unique ability of CMR to differentiate ischemic heart disease from nonischemic cardiomyopathies. Using T2-weighted techniques, areas of edema and inflammation can be identified in the myocardium. A new generation of myocardial mapping techniques are emerging, enabling direct quantitative assessment of myocardial tissue properties in absolute terms. This review will summarize recent developments involving T1-mapping and T2-mapping techniques and focus on the clinical applications and future potential of these evolving CMR methodologies. Following this activity, learners will understand various qualitative and quantitative techniques used for tissue characterization, be able to discuss clinical utility of T1 mapping techniques, and describe the errors and limitations associated with tissue characterisation MRI techniques.

Accreditation Statement

The Society for Cardiovascular Magnetic Resonance (SCMR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

The Society for Cardiovascular Magnetic Resonance (SCMR) designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions for Claiming CME

• Attend the sessions in full for which credit is sought
• Complete the post-activity evaluation
• A certificate of completion will be available once the evaluation is submitted

Financial Disclosures

The planners and faculty for this activity did not have any relevant relationships to disclose, unless listed below:
 

Dr. Ugander received research grants from Siemens and is a member on the advisory/review panel for Aten Porus Live Science.

Any resulting conflicts of interest were resolved prior to the start of the activity according to ACCME Criteria & Standards.

Disclosure of Commercial Support

SCMR received no funding to support this activity.

Bibliography

• Mahrhold et al. Eur Heart J 2002
• Risenkamort et al. Circulation CV Imaging 2015
• Kellman & Hansen JCMR 2014
• Moon et al. JCMR 2013, 15:92
• M. Puddechar Principles of magnetic resonance imaging
• He et al J Magn Reson Imaging 2013
• Messroghli DR, et al. Reson Med 2004, 52:141-6
• Higgins DM, et al, Medical Physics 2005;32(6):1738
• Chow K, et al, Magn Reson Med 2013;000:1-14
• Ugander M, et al, Eur Heart J 2012
• Mewton N, et al. Assessment of Myocardial Fibrosis with Cardiovascualr Magnetic Resonance J Am Coll Cardio 2011 Feb 22;57(8):891-903
• Kellman P, et al. Extracellular volume fraction mapping in the myocardium, Part 2: Ibutak Ckubucak Exoeruebce J Cardiovasc Magn Reson 2012, 14:64
• Giri S, et al. T2 quantification for improved detection of myocardial edema J Cardiovasc Magn Reson 2009 Dec 30;11:56 doiL 10.1186/1532-429X-11-56
• Steel K, Circulation, 2009
• Grün S, et al. JACC, 2012
• O’Hanlon R, JACC, 2010
• Higgins CB, et al. 1983 AM J Cardio
• Ugander M, et al. JACC Cardiovasc Imaging, 2012
• Ferreira VM, JACC CI, 2013
• Sado D, JMRI 2014
• Ugander M, et al. Eur Heart J 2012
• Flett A, et al. Circulation 2010
• Schelbert EB, et al. Circulation 2012